{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T04:41:30Z","timestamp":1773463290306,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:00:00Z","timestamp":1544832000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Zhejiang Provincial Medicine Health Science and Technology Program","award":["2014KYB013"],"award-info":[{"award-number":["2014KYB013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10753-018-0945-x","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T00:01:57Z","timestamp":1544832117000},"page":"904-914","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Selective Activation of Cannabinoid Receptor 2 Attenuates Myocardial Infarction via Suppressing NLRP3 Inflammasome"],"prefix":"10.1007","volume":"42","author":[{"given":"Wen","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangjun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiancheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0279-1048","authenticated-orcid":false,"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,15]]},"reference":[{"issue":"1","key":"945_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10741-010-9181-7","volume":"16","author":"JJ Gajarsa","year":"2011","unstructured":"Gajarsa, J.J., and R.A. Kloner. 2011. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities. Heart Failure Reviews 16 (1): 13\u201321. \nhttps:\/\/doi.org\/10.1007\/s10741-010-9181-7\n\n.","journal-title":"Heart Failure Reviews"},{"issue":"3","key":"945_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/HCO.0000000000000158","volume":"30","author":"NG Frangogiannis","year":"2015","unstructured":"Frangogiannis, N.G. 2015. Inflammation in cardiac injury, repair and regeneration. Current Opinion in Cardiology 30 (3): 240\u2013245. \nhttps:\/\/doi.org\/10.1097\/HCO.0000000000000158\n\n.","journal-title":"Current Opinion in Cardiology"},{"key":"945_CR3","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/eurheartj\/ehx783","volume":"39","author":"T Koenig","year":"2017","unstructured":"Koenig, T., D.G. Sedding, H.J. Wester, and T. Derlin. 2017. Seeing the unseen: post-infarction inflammation in an isolated right ventricular myocardial infarction visualized by combined cardiac magnetic resonance imaging and chemokine receptor CXCR4-targeted molecular imaging. European Heart Journal 39: 966. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehx783\n\n.","journal-title":"European Heart Journal"},{"issue":"3","key":"945_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/CIRCULATIONAHA.116.023365.","volume":"136","author":"N Borg","year":"2017","unstructured":"Borg, N., C. Alter, N. Gorldt, C. Jacoby, Z. Ding, B. Steckel, C. Quast, et al. 2017. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming. Circulation 136 (3): 297\u2013313. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023365.","journal-title":"Circulation"},{"key":"945_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","volume":"186","author":"SB Ong","year":"2018","unstructured":"Ong, S.B., S. Hernandez-Resendiz, G.E. Crespo-Avilan, R.T. Mukhametshina, X.Y. Kwek, H.A. Cabrera-Fuentes, and D.J. Hausenloy. 2018. Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacology & Therapeutics 186: 73\u201387. \nhttps:\/\/doi.org\/10.1016\/j.pharmthera.2018.01.001\n\n.","journal-title":"Pharmacology & Therapeutics"},{"key":"945_CR6","doi-asserted-by":"publisher","first-page":"944","DOI":"10.2741\/3288","volume":"14","author":"ES Graham","year":"2009","unstructured":"Graham, E.S., J.C. Ashton, and M. Glass. 2009. Cannabinoid Receptors: A brief history and what not. Frontiers in Bioscience (Landmark Edition) 14: 944\u2013957.","journal-title":"Frontiers in Bioscience (Landmark Edition)"},{"issue":"12","key":"945_CR7","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1111\/epi.13930","volume":"58","author":"S Rowley","year":"2017","unstructured":"Rowley, S., X. Sun, I.V. Lima, A. Tavenier, A.C.P. de Oliveira, S.K. Dey, and S.C. Danzer. 2017. Cannabinoid receptor 1\/2 double-knockout mice develop epilepsy. Epilepsia 58 (12): e162\u2013e166. \nhttps:\/\/doi.org\/10.1111\/epi.13930\n\n.","journal-title":"Epilepsia"},{"issue":"6441","key":"945_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro, S., K.L. Thomas, and M. Abu-Shaar. 1993. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365 (6441): 61\u201365. \nhttps:\/\/doi.org\/10.1038\/365061a0\n\n.","journal-title":"Nature"},{"issue":"5","key":"945_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.biopsych.2014.04.009","volume":"77","author":"L Deng","year":"2015","unstructured":"Deng, L., J. Guindon, A. BL Cornett, K. Mackie Makriyannis, and A.G. Hohmann. 2015. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal. Biological Psychiatry 77 (5): 475\u2013487. \nhttps:\/\/doi.org\/10.1016\/j.biopsych.2014.04.009\n\n.","journal-title":"Biological Psychiatry"},{"issue":"4","key":"945_CR10","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1159\/000447855","volume":"39","author":"X Li","year":"2016","unstructured":"Li, X., D. Han, Z. Tian, B. Gao, M. Fan, C. Li, X. Li, Y. Wang, S. Ma, and F. Cao. 2016. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-beta1\/Smad3 Pathway in Myocardial Infarction Mice. Cellular Physiology and Biochemistry 39 (4): 1521\u20131536. \nhttps:\/\/doi.org\/10.1159\/000447855\n\n.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"39","key":"945_CR11","doi-asserted-by":"publisher","first-page":"64853","DOI":"10.18632\/oncotarget.17614","volume":"8","author":"D Han","year":"2017","unstructured":"Han, D., X. Li, W.S. Fan, J.W. Chen, T. Su TT Gou, M.M. Fan, et al. 2017. Activation of cannabinoid receptor type II by AM1241 protects adipose-derived mesenchymal stem cells from oxidative damage and enhances their therapeutic efficacy in myocardial infarction mice via Stat3 activation. Oncotarget 8 (39): 64853\u201364866. \nhttps:\/\/doi.org\/10.18632\/oncotarget.17614\n\n.","journal-title":"Oncotarget"},{"issue":"1","key":"945_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1124\/pr.109.001081","volume":"62","author":"NT Snider","year":"2010","unstructured":"Snider, N.T., V.J. Walker, and P.F. Hollenberg. 2010. Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications. Pharmacological Reviews 62 (1): 136\u2013154. \nhttps:\/\/doi.org\/10.1124\/pr.109.001081\n\n.","journal-title":"Pharmacological Reviews"},{"issue":"18","key":"945_CR13","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1182\/blood-2012-06-435362","volume":"120","author":"S Adhikary","year":"2012","unstructured":"Adhikary, S., V.P. Kocieda, J.H. Yen, R.F. Tuma, and D. Ganea. 2012. Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression. Blood 120 (18): 3741\u20133749. \nhttps:\/\/doi.org\/10.1182\/blood-2012-06-435362\n\n.","journal-title":"Blood"},{"issue":"3","key":"945_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1177\/1074248415612593","volume":"21","author":"LN Maslov","year":"2016","unstructured":"Maslov, L.N., I. Khaliulin, Y. Zhang, A.V. Krylatov, N.V. Naryzhnaya, R. Mechoulam, L. De Petrocellis, and J.M. Downey. 2016. Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists. Journal of Cardiovascular Pharmacology and Therapeutics 21 (3): 262\u2013272. \nhttps:\/\/doi.org\/10.1177\/1074248415612593\n\n.","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"2","key":"945_CR15","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11427-013-4604-z.","volume":"57","author":"Y Wang","year":"2014","unstructured":"Wang, Y., S. Ma, Q. Wang, Hu W, D. Wang, X. Li, T. Su, et al. 2014. Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart. Science China. Life Sciences 57 (2): 201\u2013208. \nhttps:\/\/doi.org\/10.1007\/s11427-013-4604-z.","journal-title":"Science China. Life Sciences"},{"key":"945_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8360","volume":"6","author":"M Ito","year":"2015","unstructured":"Ito, M., T. Shichita, M. Okada, R. Komine, Y. Noguchi, A. Yoshimura, and R. Morita. 2015. Bruton\u2019s tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury. Nature Communications 6: 7360. \nhttps:\/\/doi.org\/10.1038\/ncomms8360\n\n.","journal-title":"Nature Communications"},{"issue":"1","key":"945_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12974-017-1039-7.","volume":"15","author":"T Wang","year":"2018","unstructured":"Wang, T., D. Nowrangi, Yu L, Lu T, J. Tang, B. Han, Y. Ding, Fu F, and J.H. Zhang. 2018. Activation of dopamine D1 receptor decreased NLRP3-mediated inflammation in intracerebral hemorrhage mice. Journal of Neuroinflammation 15 (1): 2. \nhttps:\/\/doi.org\/10.1186\/s12974-017-1039-7.","journal-title":"Journal of Neuroinflammation"},{"issue":"12","key":"945_CR18","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.114.013730","volume":"131","author":"A Abderrazak","year":"2015","unstructured":"Abderrazak, A., D. Couchie, D.F. Mahmood, R. Elhage, C. Vindis, M. Laffargue, V. Mateo, et al. 2015. Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet. Circulation 131 (12): 1061\u20131070. \nhttps:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013730\n\n.","journal-title":"Circulation"},{"issue":"27","key":"945_CR19","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","volume":"35","author":"PM Ridker","year":"2014","unstructured":"Ridker, P.M., and T.F. Luscher. 2014. Anti-inflammatory therapies for cardiovascular disease. European Heart Journal 35 (27): 1782\u20131791. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehu203\n\n.","journal-title":"European Heart Journal"},{"issue":"1","key":"945_CR20","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1038\/s41467-017-02351-0","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo, W., W. Liu, Z. Chen, Gu Y, S. Peng, L. Shen, Y. Shen, et al. 2017. Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis. Nature Communications 8 (1): 2168. \nhttps:\/\/doi.org\/10.1038\/s41467-017-02351-0\n\n.","journal-title":"Nature Communications"},{"issue":"5","key":"945_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"AR Mridha","year":"2017","unstructured":"Mridha, A.R., A. Wree, Robertson AAB, M.M. Yeh, C.D. Johnson, D.M. Van Rooyen, F. Haczeyni, et al. 2017. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Journal of Hepatology 66 (5): 1037\u20131046. \nhttps:\/\/doi.org\/10.1016\/j.jhep.2017.01.022\n\n.","journal-title":"Journal of Hepatology"},{"key":"945_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","volume":"15","author":"S Toldo","year":"2017","unstructured":"Toldo, S., and A. Abbate. 2017. The NLRP3 inflammasome in acute myocardial infarction. Nature Reviews. Cardiology 15: 203\u2013214. \nhttps:\/\/doi.org\/10.1038\/nrcardio.2017.161\n\n.","journal-title":"Nature Reviews. Cardiology"},{"issue":"8","key":"945_CR23","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","volume":"71","author":"S Sano","year":"2018","unstructured":"Sano, S., K. Oshima, Y. Wang, S. MacLauchlan, Y. Katanasaka, M. Sano, M.A. Zuriaga, et al. 2018. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1beta\/NLRP3 Inflammasome. Journal of the American College of Cardiology 71 (8): 875\u2013886. \nhttps:\/\/doi.org\/10.1016\/j.jacc.2017.12.037\n\n.","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"945_CR24","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/eurheartj\/ehw247","volume":"38","author":"GP Hout van","year":"2017","unstructured":"van Hout, G.P., L. Bosch, G.H. Ellenbroek, J.J. de Haan, W.W. van Solinge, M.A. Cooper, F. Arslan, et al. 2017. The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction. European Heart Journal 38 (11): 828\u2013836. \nhttps:\/\/doi.org\/10.1093\/eurheartj\/ehw247\n\n.","journal-title":"European Heart Journal"},{"issue":"12","key":"945_CR25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/cns.12349","volume":"20","author":"BZ Shao","year":"2014","unstructured":"Shao, B.Z., W. Wei, P. Ke, Xu ZQ, J.X. Zhou, and C. Liu. 2014. Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome. CNS Neuroscience & Therapeutics 20 (12): 1021\u20131028. \nhttps:\/\/doi.org\/10.1111\/cns.12349\n\n.","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"4","key":"945_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/FJC.0b013e3182418997","volume":"59","author":"PF Wang","year":"2012","unstructured":"Wang, P.F., J. Bu LS Jiang, W. XJ Huang, Y.P. Du Song, and B. He. 2012. Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury. Journal of Cardiovascular Pharmacology 59 (4): 301\u2013307. \nhttps:\/\/doi.org\/10.1097\/FJC.0b013e3182418997\n\n.","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"945_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.neuropharm.2017.01.027","volume":"119","author":"J Tang","year":"2017","unstructured":"Tang, J., H. Miao, B. Jiang, Q. Chen, L. Tan, Y. Tao, J. Zhang, et al. 2017. A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix Hemorrhage in the preterm via CX3CR1(+) microglia. Neuropharmacology 119: 157\u2013169. \nhttps:\/\/doi.org\/10.1016\/j.neuropharm.2017.01.027\n\n.","journal-title":"Neuropharmacology"},{"issue":"1","key":"945_CR28","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/hep.26598","volume":"59","author":"A Guillot","year":"2014","unstructured":"Guillot, A., N. Hamdaoui, A. Bizy, K. Zoltani, R. Souktani, E.S. Zafrani, A. Mallat, S. Lotersztajn, and F. Lafdil. 2014. Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver. Hepatology 59 (1): 296\u2013306. \nhttps:\/\/doi.org\/10.1002\/hep.26598\n\n.","journal-title":"Hepatology"},{"issue":"7","key":"945_CR29","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/all.12858","volume":"71","author":"RB Frei","year":"2016","unstructured":"Frei, R.B., P. Luschnig, G.P. Parzmair, M. Peinhaupt, S. Schranz, A. Fauland, C.E. Wheelock, A. Heinemann, and E.M. Sturm. 2016. Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen-induced pulmonary inflammation in mice. Allergy 71 (7): 944\u2013956. \nhttps:\/\/doi.org\/10.1111\/all.12858\n\n.","journal-title":"Allergy"},{"issue":"2","key":"945_CR30","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/sj.bjp.0707569","volume":"153","author":"M Rajesh","year":"2008","unstructured":"Rajesh, M., P. Mukhopadhyay, G. Hasko, J.W. Huffman, K. Mackie, and P. Pacher. 2008. CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration. British Journal of Pharmacology 153 (2): 347\u2013357. \nhttps:\/\/doi.org\/10.1038\/sj.bjp.0707569\n\n.","journal-title":"British Journal of Pharmacology"},{"issue":"4","key":"945_CR31","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3233\/JAD-130137","volume":"35","author":"E Aso","year":"2013","unstructured":"Aso, E., S. Juves, R. Maldonado, and I. Ferrer. 2013. CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in AbetaPP\/PS1 mice. Journal of Alzheimer's Disease 35 (4): 847\u2013858. \nhttps:\/\/doi.org\/10.3233\/JAD-130137\n\n.","journal-title":"Journal of Alzheimer's Disease"},{"issue":"5","key":"945_CR32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.yjmcc.2008.12.014.","volume":"46","author":"F Montecucco","year":"2009","unstructured":"Montecucco, F., S. Lenglet, V. Braunersreuther, F. Burger, G. Pelli, M. Bertolotto, F. Mach, and S. Steffens. 2009. CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia\/reperfusion. Journal of Molecular and Cellular Cardiology 46 (5): 612\u2013620. \nhttps:\/\/doi.org\/10.1016\/j.yjmcc.2008.12.014.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"3","key":"945_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1139\/cjpp-2013-0293","volume":"92","author":"Q Li","year":"2014","unstructured":"Li, Q., H.C. Guo, L.N. Maslov, X.W. Qiao, J.J. Zhou, and Y. Zhang. 2014. Mitochondrial permeability transition pore plays a role in the cardioprotection of CB2 receptor against ischemia-reperfusion injury. Canadian Journal of Physiology and Pharmacology 92 (3): 205\u2013214. \nhttps:\/\/doi.org\/10.1139\/cjpp-2013-0293\n\n.","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"945_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00333","volume":"4","author":"Y Zhong","year":"2013","unstructured":"Zhong, Y., A. Kinio, and M. Saleh. 2013. Functions of NOD-Like Receptors in Human Diseases. Frontiers in Immunology 4: 333. \nhttps:\/\/doi.org\/10.3389\/fimmu.2013.00333\n\n.","journal-title":"Frontiers in Immunology"},{"key":"945_CR35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/JIR.S51250.","volume":"8","author":"E Ozaki","year":"2015","unstructured":"Ozaki, E., M. Campbell, and S.L. Doyle. 2015. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. Journal of Inflammation Research 8: 15\u201327. \nhttps:\/\/doi.org\/10.2147\/JIR.S51250.","journal-title":"Journal of Inflammation Research"},{"key":"945_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao, B.Z., Xu ZQ, D.F. Su BZ Han, and C. Liu. 2015. NLRP3 inflammasome and its inhibitors: a review. Frontiers in Pharmacology 6: 262. \nhttps:\/\/doi.org\/10.3389\/fphar.2015.00262\n\n.","journal-title":"Frontiers in Pharmacology"},{"key":"945_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12950-015-0086-z","volume":"12","author":"EH Kim","year":"2015","unstructured":"Kim, E.H., S. Park MJ Park, and E.S. Lee. 2015. Increased expression of the NLRP3 inflammasome components in patients with Behcet\u2019s disease. Journal of Inflammation (London) 12: 41. \nhttps:\/\/doi.org\/10.1186\/s12950-015-0086-z\n\n.","journal-title":"Journal of Inflammation (London)"},{"key":"945_CR38","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.lfs.2017.08.004","volume":"186","author":"Q Wang","year":"2017","unstructured":"Wang, Q., P. Lin, P. Li, L. Feng, Q. Ren, X. Xie, and Xu J. 2017. Ghrelin protects the heart against ischemia\/reperfusion injury via inhibition of TLR4\/NLRP3 inflammasome pathway. Life Sciences 186: 50\u201358. \nhttps:\/\/doi.org\/10.1016\/j.lfs.2017.08.004\n\n.","journal-title":"Life Sciences"},{"issue":"6","key":"945_CR39","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/cvr\/cvw246","volume":"113","author":"J Valle Raleigh","year":"2017","unstructured":"Valle Raleigh, J., T. AG Mauro, C. Devarakonda, J. Marchetti, E. He, S. Kim, Filippone, et al. 2017. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia\/reperfusion injury via eNOS-dependent mechanism. Cardiovascular Research 113 (6): 609\u2013619. \nhttps:\/\/doi.org\/10.1093\/cvr\/cvw246\n\n.","journal-title":"Cardiovascular Research"},{"issue":"12","key":"945_CR40","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.3390\/ijms17122064","volume":"17","author":"Z Zhou","year":"2016","unstructured":"Zhou, Z., Z. Wang, Q. Guan, F. Qiu, Y. Li, Z. Liu, H. Zhang, H. Dong, and Z. Zhang. 2016. PEDF Inhibits the Activation of NLRP3 Inflammasome in Hypoxia Cardiomyocytes through PEDF Receptor\/Phospholipase A2. International Journal of Molecular Sciences 17 (12): 2064. \nhttps:\/\/doi.org\/10.3390\/ijms17122064\n\n.","journal-title":"International Journal of Molecular Sciences"},{"key":"945_CR41","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.bbi.2017.08.004","volume":"67","author":"F Gao","year":"2018","unstructured":"Gao, F., H.C. Xiang, H.P. Li, M. Jia, X.L. Pan, H.L. Pan, and M. Li. 2018. Electroacupuncture inhibits NLRP3 inflammasome activation through CB2 receptors in inflammatory pain. Brain, Behavior, and Immunity 67: 91\u2013100. \nhttps:\/\/doi.org\/10.1016\/j.bbi.2017.08.004\n\n.","journal-title":"Brain, Behavior, and Immunity"},{"issue":"9","key":"945_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155076","volume":"11","author":"P Ke","year":"2016","unstructured":"Ke, P., Z.Q. Xu BZ Shao, W. Wei, B.Z. Han, X.W. Chen, Su DF, and C. Liu. 2016. Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages. PLoS One 11 (9): e0155076. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0155076\n\n.","journal-title":"PLoS One"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-018-0945-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-018-0945-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-018-0945-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,14]],"date-time":"2019-12-14T19:07:50Z","timestamp":1576350470000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-018-0945-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,15]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["945"],"URL":"https:\/\/doi.org\/10.1007\/s10753-018-0945-x","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,15]]},"assertion":[{"value":"15 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}